Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 45 | $84,181,946 |
| Sells | 106 | $271,602,767 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Oct 2024 16:17 | UPB | Upstream Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Oct 2024 | Purchase | 165,000 | 17 | 2,805,000 | I |
| 17 Oct 2024 16:17 | UPB | Upstream Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Oct 2024 | Purchase | 660,000 | 17 | 11,220,000 | I |
| 23 Sep 2024 16:51 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 19 Sep 2024 | Sale | 39,300 | 0.71 | 27,903 | I |
| 18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 18 Sep 2024 | Sale | 25,631 | 0.73 | 18,711 | I |
| 18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 17 Sep 2024 | Sale | 111,400 | 0.73 | 81,322 | I |
| 18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 16 Sep 2024 | Sale | 63,100 | 0.74 | 46,694 | I |
| 17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 250,000 | 16 | 4,000,000 | I |
| 17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 500,000 | 16 | 8,000,000 | I |
| 28 Aug 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
| 15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 29,400 | 44.01 | 1,293,894 | I |
| 15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 220,600 | 44.01 | 9,708,606 | I |
| 15 Aug 2024 16:51 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 13 Aug 2024 | Purchase | 21,658 | 4 | 86,632 | I |
| 15 Aug 2024 16:51 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 13 Aug 2024 | Purchase | 478,342 | 4 | 1,913,368 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 623 | 10 | 6,230 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 556 | 10 | 5,560 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 4,009 | 10 | 40,090 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 6,142 | 10 | 61,420 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 5,401 | 10 | 54,010 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 39,433 | 10 | 394,330 | I |
| 02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 02 Jul 2024 | Sale | 36,600 | 4.54 | 166,164 | I |
| 02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 01 Jul 2024 | Sale | 13,700 | 4.68 | 64,116 | I |
| 02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 28 Jun 2024 | Sale | 378,000 | 4.74 | 1,791,720 | I |
| 20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 10,986 | 36 | 395,496 | I |
| 20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 43,944 | 36 | 1,581,984 | I |
| 20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 28,404 | 36 | 1,022,544 | I |
| 20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 1,000,000 | 22.14 | 22,140,000 | I |
| 20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 33,300 | 22.14 | 737,262 | I |
| 03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 03 May 2024 | Sale | 4,674 | 14.03 | 65,576 | I |
| 03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 02 May 2024 | Sale | 8,842 | 14.01 | 123,876 | I |
| 03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 01 May 2024 | Sale | 15,690 | 14.02 | 219,974 | I |
| 26 Apr 2024 17:01 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 24 Apr 2024 | Sale | 1,781 | 14.06 | 25,041 | I |
| 23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 23 Apr 2024 | Sale | 21,791 | 14.29 | 311,393 | I |
| 23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 22 Apr 2024 | Sale | 24,609 | 14.05 | 345,756 | I |
| 23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 19 Apr 2024 | Sale | 18,253 | 14.02 | 255,907 | I |
| 18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 18 Apr 2024 | Sale | 2,623 | 14.06 | 36,879 | I |
| 18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 17 Apr 2024 | Sale | 300 | 14.15 | 4,245 | I |
| 18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 16 Apr 2024 | Sale | 14,069 | 14.01 | 197,107 | I |
| 15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2024 | Sale | 461,899 | 14.49 | 6,692,917 | I |
| 15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 12 Apr 2024 | Sale | 23,101 | 14.42 | 333,116 | I |
| 31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
| 31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,041,700 | 2.4 | 2,500,080 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 242,200 | 2.4 | 581,280 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,841,100 | 2.4 | 4,418,640 | I |
| 25 Jan 2024 16:28 | EWTX | Edgewise Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 139,166 | 18.32 | 2,549,521 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 1,195,683 | 18.32 | 21,904,913 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 3,128 | 19.82 | 61,997 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 26,872 | 19.82 | 532,603 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 18,922 | 19.96 | 377,683 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 162,576 | 19.96 | 3,245,017 | I |
| 20 Dec 2023 18:28 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 18 Dec 2023 | Sale | 1,724 | 59.24 | 102,130 | D |
| 15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 57,100 | 56.75 | 3,240,425 | I |
| 15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 228,500 | 56.75 | 12,967,375 | I |
| 15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 147,600 | 56.75 | 8,376,300 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 100 | 57.73 | 5,773 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 100 | 57.73 | 5,773 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 14,100 | 58.56 | 825,696 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 36,400 | 58.56 | 2,131,584 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 56,200 | 58.56 | 3,291,072 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 9,300 | 60.16 | 559,488 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 3,600 | 60.16 | 216,576 | I |
| 14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 14,400 | 60.16 | 866,304 | I |
| 24 Nov 2023 16:38 | PMVP | PMV Pharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 22 Nov 2023 | Sale | 87,786 | 2.23 | 195,763 | I |
| 04 Oct 2023 17:36 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 03 Oct 2023 | Sale | 700 | 9.02 | 6,314 | I |
| 04 Oct 2023 17:36 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 02 Oct 2023 | Sale | 7,614 | 9.08 | 69,135 | I |
| 31 Aug 2023 17:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 29 Aug 2023 | Purchase | 500,000 | 6.2 | 3,100,000 | I |
| 17 Aug 2023 16:40 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 15 Aug 2023 | Sale | 535,534 | 0.75 | 401,650 | I |
| 17 Aug 2023 16:40 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 15 Aug 2023 | Sale | 248,819 | 0.75 | 186,614 | I |
| 17 Aug 2023 16:40 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 15 Aug 2023 | Sale | 38,327 | 0.75 | 28,745 | I |
| 02 Aug 2023 17:05 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 31 Jul 2023 | Sale | 153,078 | 3 | 459,234 | I |
| 02 Aug 2023 17:05 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 31 Jul 2023 | Sale | 29,700 | 3 | 89,100 | I |
| 02 Aug 2023 17:05 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 31 Jul 2023 | Sale | 26,622 | 3 | 79,866 | I |
| 27 Jul 2023 16:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 25 Jul 2023 | Sale | 4,700 | 2.92 | 13,724 | I |
| 27 Jul 2023 16:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 25 Jul 2023 | Sale | 26,700 | 2.92 | 77,964 | I |
| 27 Jul 2023 16:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 25 Jul 2023 | Sale | 7,800 | 2.92 | 22,776 | I |
| 24 Jul 2023 16:38 | TSBX | Turnstone Biologics Corp | ORBIMED ADVISORS LLC | Director , 10% | 20 Jul 2023 | Purchase | 416,666 | 12 | 4,999,992 | I |
| 19 Jul 2023 16:15 | THRX | Theseus Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 17 Jul 2023 | Purchase | 151,450 | 3.05 | 461,922 | I |
| 19 Jul 2023 16:15 | THRX | Theseus Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 17 Jul 2023 | Purchase | 328,482 | 3.05 | 1,001,870 | I |
| 17 Jul 2023 16:13 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Jul 2023 | Sale | 132,100 | 2.4 | 317,040 | I |
| 17 Jul 2023 16:13 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Jul 2023 | Sale | 52,800 | 2.4 | 126,720 | I |
| 17 Jul 2023 16:13 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Jul 2023 | Sale | 9,800 | 2.4 | 23,520 | I |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 58,000 | 2.09 | 121,220 | I |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 442,000 | 2.09 | 923,780 | I |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 250,000 | 2.09 | 522,500 | I |
| 29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 125,000 | 2.09 | 261,250 | I |
| 29 Jun 2023 16:42 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 28 Jun 2023 | Purchase | 575,195 | 0.84 | 483,164 | I |
| 29 Jun 2023 16:42 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 27 Jun 2023 | Purchase | 617,382 | 0.84 | 518,601 | I |
| 24 May 2023 17:09 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 22 May 2023 | Purchase | 869,565 | 5.75 | 4,999,999 | I |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 345,313 | 20 | 6,906,260 | I |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 14,400 | 21.96 | 316,224 | I |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 12 May 2023 | Sale | 43,200 | 21.64 | 934,848 | I |
| 15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 11 May 2023 | Sale | 80,000 | 22.26 | 1,780,800 | I |
| 08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,511 | 2.82 | 1,383,241 | I |
| 08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,512 | 2.82 | 1,383,244 | I |
| 08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 04 May 2023 | Purchase | 83,459 | 2.75 | 229,512 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)